Prosecution Insights
Last updated: April 19, 2026

Examiner: ALAWADI, SARAH

Tech Center 1600 • Art Units: 1619

This examiner grants 37% of resolved cases

Performance Statistics

37.4%
Allow Rate
-22.6% vs TC avg
713
Total Applications
+38.7%
Interview Lift
1354
Avg Prosecution Days
Based on 661 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
13.5%
§102 Novelty
46.4%
§103 Obviousness
21.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19289461 SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS Non-Final OA DSM IP ASSETS B.V.
18263641 SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS Non-Final OA DSM IP ASSETS B.V.
17298057 TOPICAL ANTIMICROBIAL MICROEMULSIONS WITH FLUORESCENT MATERIALS Non-Final OA Solventum Intellectual Properties Company
18252600 MARINE COATING COMPOSITION Final Rejection BAE SYSTEMS plc
18298042 MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF  Non-Final OA The Trustees of Columbia University in the City of New York
18286771 USE OF A CATIONIC POLYMER FOR REINFECTION PREVENTION Non-Final OA Conopco, Inc., d/b/a UNILEVER
18286492 CLEANSING COMPOSITION FOR FEMALE INTIMATE HYGIENE Non-Final OA Conopco, Inc., d/b/a UNILEVER
18492486 Hair Perming Compositions With Amine Derivatives Non-Final OA ELC Management LLC
18045575 TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME Final Rejection INOVIO PHARMACEUTICALS, INC.
18559940 SKIN CARE COMPOSITION CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND ALKYLENE OXIDE DERIVATIVE Non-Final OA SHISEIDO COMPANY, LTD.
18254009 THERAPEUTIC COMPOSITIONS FOR ENHANCED HEALING OF WOUNDS AND SCARS Non-Final OA LOCUS SOLUTIONS IPCO, LLC
18015159 SILVER ENHANCED CANNABINOID ANTIBIOTICS Final Rejection The University of British Columbia
18608901 DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION Non-Final OA GENEXA INC.
18201375 SYRUP FORMULATION OR SUSPENSION Non-Final OA GENEXA INC.
18245206 COSMETIC COMPOSITION OF LOW OSMOLALITY Final Rejection BEIERSDORF AG
18197791 ANTI-MICROBIAL COMPOSITION Final Rejection UWM Research Foundation, Inc.
18416774 DRUG DELIVERY SYSTEM Non-Final OA EB IP Hybritabs B. V.
18532935 ANTIBACTERIAL DRESSING, METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF Non-Final OA Suzhou Microport Regenerative Medicine Technology Co. Ltd
18563062 ANTIVIRAL COMPOSITION AND ANTIVIRAL MEMBER Non-Final OA NATIONAL INSTITUTE OF TECHNOLOGY
18386831 NASAL ANTISEPTIC Non-Final OA PoviNez LLC
18557089 TOPICAL FORMULATIONS COMPRISING BENZOYL PEROXIDE AND AZELAIC ACID, AND USE THEREOF Non-Final OA NOON AESTHETICS M.R. LTD.
17781862 Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same Final Rejection L&C Bio Co., Ltd.
18463663 COMPOSITION FOR SKIN TREATMENT AND METHODS Non-Final OA DERMAZEN, LLC
18249253 GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES Non-Final OA SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
18258456 ANTIMICROBIAL AGENT COMPOSITION AND MANUFACTURING METHOD AND PRODUCT THEREOF Non-Final OA Dong Chul IHN
18016655 METHODS OF TREATING CONDITIONS RESPONSIVE TO NTIRIC OXIDE THERAPY Final Rejection SaNOtize Research and Development Corp.
18033383 Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues Non-Final OA Dzala LLC
18030680 MESOPOROUS NANOPARTICLES SYSTEM TO INCREASE THE BIOFILM ERADICATION ACTIVITY BY MEANS OF THE CARRYING AND THE ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT AND RELATED PRODUCTION METHOD Non-Final OA Brenta S.r.l.
18248020 COMBINATIONS TREATMENTS Non-Final OA Aequor, Inc.
18006744 Anti-Microbial Compositions Final Rejection 5D HEALTH PROTECTION GROUP LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month